DIALYSIS · CCN 332772

USRC Amherst Dialysis

TONAWANDA, NY 14150

DialysisProfitUS Renal Care, Inc.
$3.2M
TOTAL REVENUE
0.5%
OPERATING MARGIN
2 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.2M
Total costs
$3.2M
Operating income (rev − costs)
$17K
Operating margin
0.5%
Total charges
$3.2M
Total treatments
8,055
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9561—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9228—
Fistula Rate
DFC_FISTULA_RATE
4970—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.5145—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
96.751—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
163—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2470—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
26.9214—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
17.753—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
15.527—
Standardized ED Visits Ratio
DFC_SEDR
0.3724—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
72.322—